Skip to main content
. 2022 Oct 26;9(5):470–475. doi: 10.14744/nci.2021.90094

Table 2.

Comparison of patients by gender

Female (n=168) Male (n=288) p
Age 69.07±12.76 66.69±12.51 0.333
BMI 24.8±3.5 23.6±2.7 0.789
GH (<1 ng/ml) 0.251±0.27 0.270±0.33 0.762
IGF-1(ng/ml) 68.20±32.01 65.22±34.02 0.647
AST (7–40 U/L) 23.23±9.84 25.03±10.89 0.604
ALT (7–40 U/L) 27.30±11.20 28.53±21.98 0.337
GFR 77.90±24.70 82.32±22.64 0.348
Creatinine (<1 mg/dl) 0.89±0.29 0.99±0.35 0.685
Glucose (70–100 mg/dl) 112.57±14.59 117.46±14.94 0.525
HBA1C (<6.5%) 6.48±1.44 6.73±1.45 0.731
CRP (<5 mg/L) 62.30±60.77 92.84±65.81 0.016
Hospital stay 6.62±1.30 8.90±2.91 0.036

BMI: Body mass index; GH: Growth hormone; IGF-I: Insulin-like growth factor-I; HbA1c: Glycosylated hemoglobin; ALT: Alanine amino transferase; AST: Aspartate amino transferase; BUN: Blood urea nitrogen; eGFR: Estimated glomerular filtration rate; CRP: C reactive protein.